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Multimorbidity is a game changer
Battegay Edouard
Department of Internal Medicine, University Hospital Zurich, Switzerland
We generally analyse, classify, understand and teach dis-
eases from the perspective of genetics, pathophysiology,
anatomy, and then of course specific organ systems. How-
ever, patients nowadays accumulate multiple chronic con-
ditions. If treated appropriately, hypertension, heart failure,
diabetes, human immunodeficiency virus infection, some
types of cancer and haematological malignancies, as well
as many other diseases, have lost the fear of former times
and have become chronic conditions, although many dis-
eases with high rates of morbidity and mortality still exist.
This success of medicine is still ongoing and increases the
emergence of multiple chronic coincident conditions in a
single patient, i.e., multimorbidity. This megatrend in med-
icine necessitates changes in ways to manage diseases, pa-
tients and institutions in health care.
In an article now published in the Swiss Medical Weekly,
Aubert et al. [1] address thought-provoking issues con-
cerning multimorbidity. The authors conducted a multicen-
tre retrospective study in 42,739 patients discharged from
general internal medicine departments in three major Swiss
hospitals. They defined multimorbidity as ≥2 chronic dis-
eases and found that 79% of the patients in these hospitals
to be multimorbid, with a median of four chronic diseases
per patient [1]. Nowadays, acute diseases mostly emerge
from deterioration of chronic diseases, such as acute heart
failure from chronic heart disease and acutely exacerbat-
ed chronic obstructive pulmonary disease (COPD) from
chronic COPD. Yet this is not always the case. As stated
by the authors, their estimate of the extent of multimor-
bidity may therefore even be an underestimation of its true
prevalence, as acute diseases were excluded from some of
their analyses. Also, retrospective analyses tend to under-
estimate the number of morbidities because treating physi-
cians may have underreported those deemed irrelevant to
the current hospitalisation.
On the other hand, just counting morbidities may lead to
overestimating the challenges of multimorbidity. The Na-
tional Library of Medicine (NLM, Pubmed) has recently
defined the MESH term “multimorbidity” to be “the com-
plex interactions of several co-existing diseases” [2], i.e.,
not the “accumulation of chronic or chronic and acute dis-
eases”. It would probably have been wise for the NLM
to use a different term for this clinically relevant per-
spective on multimorbidity such as “complex multimor-
bidity”. This definition of multimorbidity takes account of
interactions between diseases, namely disease-disease in-
teractions (DDIs) [2]. Examples of prevalent DDIs include
hypertension and pain management with nonsteroidal anti-
inflammatory drugs, gastrointestinal bleeding due to duo-
denal ulcer and the necessity for anticoagulation because
of a mechanical heart valve, or high-dose corticosteroid
therapy for asthma and concurrent diabetes [3]. In a small
retrospective, single centre study with a prevalence of mul-
timorbidity similar to the study by Aubert et al. [1], we
found 49% of patients with multiple acute and chronic
conditions to have more or less severe DDIs [4]. This
latter percentage may also be an underestimate because
of the retrospective design of our study. But whatever the
perspective on multimorbidity or complex multimorbidity
will be, the extent of this entity in healthcare settings is
staggering and overwhelming in both in-patient [4] and
out-patient [3] care. This requires much further detailed
analysis of multimorbidity and complex multimorbidity as
regards patients, institutions, healthcare in general, educa-
tion and training.
In this vein, Aubert et al. demonstrated a very interesting
analysis in figure 4 of their paper [1]. They put the four
most prevalent comorbidities, occurring in ≥10% of the pa-
tients (chronic heart disease, chronic kidney disease, sol-
id malignancy, substance-related disorders) at centre stage
and precisely delineated a complex network of overlapping
and interacting clusters of conditions. As suggested by the
above-mentioned new definition of the NLM [2] and nice-
ly shown in this complex analysis [1], multimorbidity is
not only a quantitative concept. There are very specific, re-
producible and sometimes singular disease combinations,
i.e., disease clusters. The number of potential combinations
is extremely high. Some are very prevalent [1], others
again rare or even singular, i.e., finger-printable or person-
alisable. Clusters are not a coincidence [1, 3, 4]. They re-
sult from the prevalence of diseases, from genetics, and
from behaviours or environmental as well as occupational
influences. For example, smoking or the failure to stop
smoking may be due to depression and/or generalised anx-
iety. Thus, smoking, or perhaps rather the failure to end
it, may sometimes represent an attempt to control anxiety.
However, smoking will also lead to atherosclerosis, COPD
and cancer in various constellations. From a public health
perspective, such clusters result from the failure to more
aggressively address smoking or perhaps depression and
anxiety as a most pressing health issue. Thus, substance-re-
lated disorders also coincide with heart disease, solid ma-
lignancy and lung disease (see figure 4 in the article by
Aubert et al. [1]). Therefore, disease clusters need con-
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stant monitoring to better guide public health policy and
intervention. Multimorbidity alters the perspective on dis-
ease management, case management and patient care. It
calls for managing single diseases in the light of conflict-
ing management of other diseases, as well as of patients
with multiple diseases and conditions. It impacts on insti-
tutions and organisations of health care, especially as pop-
ulations are aging and functional decline may form specif-
ic clusters with multimorbidity.
Since the 1950s we have seen an unprecedented and ever-
increasing specialisation and fragmentation, perhaps even
atomisation of health care. An endocrine organ of a very
few grams and relatively few related diseases may be cov-
ered in a central hospital by a distinguished, highly respect-
ed specialist. A number of different specialists tending to
each organ or disease will treat patients with complex mul-
timorbidity. Unfortunately, doctors sometimes defer coor-
dination between mutually exclusive management options
to patients or their relatives in a badly adapted version of
“patient choice”. The fragmentation and disintegration of
health and patient care may endanger clarity and leader-
ship in guiding complex multimorbid patients. The care
(or rather non-care?) for multimorbid patients has substan-
tially contributed to ever increasing health costs. Thus,
systems, institutions and caregivers serve complex multi-
morbid patients often inadequately and inefficiently. This
requires some caregivers to very consciously specialise to
ensure coherence, continuity and coordination in the care
of complex multimorbid patients. The American College
of Physicians in its concept paper on the “Advanced Med-
ical Home” [5], the European Federation of Internal Med-
icine in its statement on training requirements for Internal
Medicine [6] and proponents of general internal medi-
cine at university and teaching hospitals in Switzerland
[7] strongly advocate for recognised roles for general in-
ternists and hospitalists. Multimorbidity and interactions
between multiple diseases (DDIs) require specific research
and highly sophisticated know-how, and must be a highly
respected specialisation by itself. These specialists togeth-
er with other healthcare givers ought to organise care to
lower the burden of multimorbidity for patients, institu-
tions and health care in general. Complex multimorbidity
is a reality now. The policy of health care, institutions and
caregivers need to change the game, there is no choice.
Disclosure statement
No financial support and no other potential conflict of interest relevant
to this article was reported.
References
1 Aubert CE, Fankhauser N, Vasques-Vidal PM, Stirnemann J, Aujesky D,
Limacher A, et al. Patterns of multimorbidity in internal medicine pa-
tients in Swiss university hospitals: a multicentre cohort study. Swiss
Med Wkly. 2019;149:. doi: http://dx.doi.org/10.4414/smw.2019.20094.
PubMed.
2 https://www.ncbi.nlm.nih.gov/mesh/?term=multimorbidity
3 Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini
S. Multimorbiditätsmanagement im Alltagsdilemma [Multimorbidity
management and the physician’s daily clinical dilemma]. Internist
(Berl). 2017;58(4):344–53. Article in German. doi: http://dx.doi.org/
10.1007/s00108-017-0200-9. PubMed.
4 Markun S, Holzer BM, Rodak R, Kaplan V, Wagner CC, Battegay E, et
al. Therapeutic conflicts in emergency department patients with multi-
morbidity: a cross-sectional study. PLoS One. 2014;9(10):. doi:
http://dx.doi.org/10.1371/journal.pone.0110309. PubMed.
5 American College of Physicians. The advanced medical home: a patient-
centered, physician-guided model of health care. Philadelphia: American
College of Physicians; 2005: Position Paper. Available at:
https://www.acponline.org/acp_policy/policies/adv_medicalhome_pa-
tient_centered_model_healthcare_2006.pdf
6 Training requirements for the specialty of internal medicine. European
standards of postgraduate medical specialist training. Available at:
http://www.efim.org/system/files/downloads/efim_eu_curriculum.pdf
7 Aujesky D, Bassetti S, Battegay E, Cornuz J, Hess C, Leuppi JD, et al.
Aktionsplan für die universitäre allgemeine Innere Medizin. Schweiz
Arzteztg. 2018;99(38):1262–5. doi: http://dx.doi.org/10.4414/
saez.2018.06954.
Viewpoint Swiss Med Wkly. 2019;149:w20131
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 2 of 2
